Thekkinkattil Dinesh, Vidya Raghavan, Kwong Ava, Alajmi Adil Aljarrah, Mutebi Miriam, Gulluoglu Bahadir, Deo Suryanarayana, Fukuma Eisuke, Elder Elisabeth, Gonzalez Eduardo, Warnberg Fredrik, Buccimazza Iness, Ung Owen, Walker Melanie, Vernet-Tomas Maria, Peeters Marie-Jeanne Tfd Vrancken, Johnson Nathalie, Paulinelli Regis Resende, Kuehn Thorsten, Veronesi Paolo, Sarkar Diptendra, Dietz Jill
Lincoln Breast Unit, Lincoln County Hospital, United Lincolnshire Hospitals NHS Trust, Lincoln LN2 5QY, U.K.
The Royal Wolverhampton Hospital NHS Trust, Wolverhampton WV10 0QP, U.K.
Ecancermedicalscience. 2022 Sep 2;16:1443. doi: 10.3332/ecancer.2022.1443. eCollection 2022.
Breast cancer is the most common cancer in women worldwide with an estimated 2.3 million breast cancer cases diagnosed annually. The outcome of breast cancer management varies widely across the globe which could be due to a multitude of factors. Hence, a blanket approach in standardisation of care across the world is neither practical nor feasible.
To assess the extent and type of variability in breast cancer management across the globe and to do a gap analysis of patient care pathway.
An online questionnaire survey and virtual consensus meeting was carried out amongst 31 experts from 25 countries in the field of breast cancer surgical management. The questionnaire was designed to understand the variability in diagnosis and treatment of breast cancer, and potential factors contributing to this heterogeneity.
The questionnaire survey shows a wide variation in breast surgical training, diagnosis and treatment pathways for breast cancer patients. There are several factors such as socioeconomic status, patient culture and preferences, lack of national screening programmes and training, and paucity of resources, which are barriers to the consistent delivery of high-quality care in different parts of the world.
On-line survey platforms distributed to global experts in breast cancer care can assess gaps in the diagnosis and treatment of breast cancer patients. This survey confirms the need for an in-depth gap analysis of patient care pathways and treatments to enable the development of personalised plans and policies to standardise high quality care.
乳腺癌是全球女性中最常见的癌症，估计每年有230万例乳腺癌病例被诊断出来。全球乳腺癌治疗结果差异很大，这可能是由多种因素造成的。因此，在全球范围内采用统一的护理标准化方法既不实际也不可行。
评估全球乳腺癌治疗的差异程度和类型，并对患者护理路径进行差距分析。
在来自25个国家的31位乳腺癌外科治疗领域专家中开展了一项在线问卷调查和虚拟共识会议。该问卷旨在了解乳腺癌诊断和治疗的差异，以及导致这种异质性的潜在因素。
问卷调查显示，乳腺癌患者的外科培训、诊断和治疗路径存在很大差异。社会经济地位、患者文化和偏好、缺乏国家筛查计划和培训以及资源匮乏等几个因素，是世界不同地区持续提供高质量护理的障碍。
分发给全球乳腺癌护理专家的在线调查平台可以评估乳腺癌患者诊断和治疗方面的差距。这项调查证实，需要对患者护理路径和治疗进行深入的差距分析，以便制定个性化计划和政策，实现高质量护理的标准化。
